Condiciones de salud que jengibre puede ayudar a apoyar.
Ginger has been used for over 2,500 years in traditional Chinese medicine to relieve gastrointestinal discomfort, including bloating and abdominal pain. Clinical reviews and systematic studies show it accelerates gastric emptying, modulates gut motility, and reduces IBS-related symptoms. A 2024 systematic review of clinical trials confirmed its role in relieving bowel-related abdominal discomfort.
Ginger acts as a prokinetic agent, accelerating gastric emptying and reducing intragastric pressure, indirectly alleviating acid reflux. A 2011 double-blind study found 1.2 g ginger significantly accelerated gastric emptying in functional dyspepsia patients (half-emptying time reduced from 16.1 to 12.3 min). Its phenolic compounds reduce gastric contractions and esophageal inflammation. Traditional use in Ayurvedic and Chinese medicine for heartburn and dyspepsia spans millennia.
Ginger (Zingiber officinale) constituents 6-gingerol and 6-shogaol modulate Th1/Th2 balance, inhibit mast cell activity, and reduce oxidative stress. A randomized controlled trial compared ginger extract to loratadine in allergic rhinitis patients, with early clinical evidence of comparable symptom reduction. Preclinical data show suppression of mast cell infiltration in nasal mucosa and reduced OVA-specific IgE.
Ginger's bioactive compounds—principally 6-gingerol, 6-shogaol, and paradols—demonstrate well-characterized antioxidant activity in human and animal studies. These compounds scavenge reactive oxygen species, upregulate endogenous antioxidant enzymes (SOD, catalase, glutathione), and inhibit lipid peroxidation. Clinical studies confirm improved antioxidant biomarkers in supplemented individuals.
Ginger has been studied for its potential to modulate appetite and support weight management. A 2018 systematic review identified potential mechanisms including thermogenesis, lipolysis, suppression of lipogenesis, and appetite control. Human clinical evidence is limited and results are inconsistent, with only slight changes in anthropometric measurements observed in most trials.
Ginger (Zingiber officinale) exhibits anti-inflammatory and antithrombotic properties relevant to arterial health. It inhibits TXA2-induced platelet aggregation, reduces LDL oxidation, and may improve endothelial function. Ginger was included in a clinical arterial health formula (Weider Artery Health) for managing C-reactive protein. A 2025 PubMed review classified ginger among botanicals with anti-inflammatory vascular activity.
Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit prostaglandin and leukotriene synthesis, with traditional use in Ayurvedic and Chinese medicine for arthritis. Several small RCTs show modest OA pain reduction; a Cochrane-cited review notes limited efficacy in OA, though traditional use is well established.
Ginger bioactives (6-gingerol, 6-shogaol) modulate Th1/Th2 cytokine balance, mast cell activity, and oxidative stress, with early clinical evidence in rhinitis and asthma. Ginger constituents have been documented in a Cochrane-referenced systematic review of herbal interventions for asthma, and a 2025 comprehensive review confirmed early clinical evidence in asthma.
Ginger and its active constituents (gingerols, shogaols, and zingerone) have anti-inflammatory and immunomodulatory properties studied in rheumatoid arthritis and other autoimmune-related inflammatory conditions. Meta-analyses of RCTs in RA support reductions in pain, stiffness, and inflammatory markers. Ginger inhibits arachidonic acid pathways and NF-κB signaling.
Ginger (Zingiber officinale) has been studied in RCTs for chronic low back pain, with a PMC narrative review of the last decade's RCTs confirming clinical use for dysmenorrhea, muscle soreness, osteoarthritis, and chronic LBP. Its mechanism involves inhibition of prostaglandin synthesis via COX and LOX pathways. A clinical trial involving aromatic ginger oil found efficacy in chronic LBP, and multiple studies show anti-inflammatory effects.
Ginger contains gingerols and shogaols that inhibit platelet aggregation by suppressing arachidonic acid metabolism and TXA2 synthesis. A systematic review confirmed antiplatelet effects across multiple in vitro and in vivo studies. Recent PubMed research identified ginger-derived 6-paradol and 10-gingerol as novel vitamin K epoxide reductase (VKOR) inhibitors extending anticoagulant mechanisms.
Ginger supplementation has been assessed in multiple RCTs and a systematic review and meta-analysis for blood pressure reduction, with significant effects found particularly in studies using higher doses and longer durations. Mechanisms include calcium channel antagonism, ACE inhibition, and vasodilatory prostaglandin effects.
Multiple RCTs and meta-analyses support ginger's ability to reduce fasting blood glucose and HbA1c in type 2 diabetic patients. A meta-analysis of 10 RCTs (490 individuals) found a pooled weighted mean difference in HbA1c of −1.00 (95% CI: −1.56, −0.44; P<0.001). Results in non-diabetic populations are more modest.
Ginger contains gingerols and shogaols that inhibit COX-2 and LOX enzymes, reducing joint inflammation. A 2015 meta-analysis in Osteoarthritis and Cartilage found ginger significantly reduced pain and disability in OA. Podiatric specialists list ginger among the top-ranked supplements for bunion and big toe joint pain relief.
Ginger is cited for bursitis by multiple integrative medicine sources and evaluated by NCCIH for musculoskeletal inflammation. Its gingerols and shogaols inhibit both COX-2 and 5-LOX pathways. A 2025 RCT showed ginger supplementation improved pain, stiffness, and functional capacity while reducing IL-6, TNF-α, and CRP in joint pain subjects.
Ginger (Zingiber officinale) and its active constituents gingerol and shogaol have demonstrated antifungal and anti-biofilm activity against Candida albicans in in vitro studies. Gingerol inhibits Candida biofilm formation and disrupts fungal cell membrane function. Ginger has a long traditional use in Ayurvedic and Traditional Chinese Medicine for digestive infections.
Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit COX-1, COX-2, and 5-LOX enzymes, reducing inflammatory prostaglandins and leukotrienes involved in cartilage degradation. A meta-analysis of RCTs (Bartels et al., Osteoarthritis Cartilage 2015) found ginger supplementation modestly but significantly reduced OA pain and disability. A 2022 network meta-analysis identified ginger among nutraceuticals with clinical evidence for knee OA.
Clinical trials and systematic reviews show that ginger supplementation can reduce total cholesterol, LDL, and triglycerides, with some evidence of HDL improvement. Effects appear dose- and duration-dependent. A 2025 umbrella review confirmed a significant positive influence on blood lipid profile across multiple RCTs.
Ginger has well-documented anti-inflammatory bioactive compounds — primarily gingerols and shogaols — that suppress key inflammatory pathways including COX-2, LOX, and NF-κB. Multiple RCTs and several meta-analyses confirm statistically significant reductions in circulating inflammatory markers (CRP, hs-CRP, TNF-α) following supplementation. Evidence is strongest in populations with chronic inflammatory conditions such as osteoarthritis and type 2 diabetes, though effect sizes are generally modest and trial quality is variable.
Ginger (Zingiber officinale) inhibits prostaglandin synthesis via COX and LOX pathways and acts as a TRPV1 agonist. A 2014 Cochrane review cited ginger among herbs with modest OA pain benefits. Multiple RCTs support its use for osteoarthritis, chronic low-back pain, dysmenorrhea, and migraine, with moderate-to-high quality evidence.
Ginger (Zingiber officinale) supports circulation through multiple mechanisms: inhibition of platelet aggregation (anti-thrombotic), vasodilation via NO and prostaglandin pathways, and reduction of vascular inflammation. It is a traditional circulatory herb in Ayurvedic, TCM, and European herbal medicine. Clinical studies confirm antiplatelet and mild blood-pressure-lowering effects, improving blood flow at typical dietary and supplemental doses.
Ginger (Zingiber officinale) is included in multi-herb colic relief preparations that have shown clinical benefit in open-label and controlled trials. It contributes carminative and antispasmodic effects to combination products such as gripe water formulas tested for infantile colic. Traditional use of ginger for infant colic is widespread across multiple cultures.
Ginger (Zingiber officinale) has been investigated in a registered RCT for active ulcerative colitis; its bioactive compounds (shogaols, gingerols) have anti-inflammatory and antioxidant properties. A meta-analysis of polyphenols in UC confirmed ginger powder reduces clinical activity scores in UC patients.
Ginger (Zingiber officinale) is a well-documented prokinetic herb that stimulates gastrointestinal motility and increases colonic peristalsis, making it relevant to colon cleansing as a motility enhancer. Multiple RCTs have demonstrated its efficacy in accelerating gastric emptying and intestinal transit. Widely used in Ayurvedic, Chinese, and Western herbal colon-cleanse formulations.
Ginger (Zingiber officinale) promotes GI motility through gingerols and shogaols that act as 5-HT4 receptor agonists and motilin agonists, stimulating gastric emptying and intestinal peristalsis. A meta-analysis of 5 RCTs confirmed ginger accelerates gastric emptying in humans. Herbal authorities cite ginger for constipation via GI motility enhancement; German Commission E approved ginger for dyspepsia and GI motility.
Ginger (Zingiber officinale) has preclinical and clinical evidence for reducing diarrhea-predominant IBS symptoms. Animal studies show ginger significantly reduced defecation frequency, fecal water content, and colonic inflammation in IBS-D models, with effects equivalent to rifaximin. Human studies suggest ginger helps reduce pain and stool changes in IBS-D. It is listed in complementary medicine databases as a proposed treatment for diarrhea.
Ginger has established prokinetic and digestive-stimulant effects supported by clinical trials. It accelerates gastric emptying, enhances gastrointestinal motility, reduces dyspepsia symptoms, and is proposed to stimulate bile and pancreatic enzyme secretion. A systematic review of clinical trials (PMC6341159) confirmed ginger as useful for multiple gastrointestinal symptoms.
Ginger has been clinically evaluated as a sialagogue for xerostomia. A triple-blind RCT in 105 diabetic patients showed ginger mouthwash (20 mL, 3× daily for 14 days) produced the most pronounced reduction in xerostomia symptoms compared to aloe vera and saline. Its mechanism involves parasympathetic stimulation via muscarinic M3 receptors.
A double-blind RCT (n=100 infertile men) found that 500 mg/day ginger powder for 3 months significantly reduced sperm DNA fragmentation (SDF) compared to placebo (p=0.02). A systematic review confirmed ginger enhances sperm count, viability, motility, morphology, and DNA integrity via antioxidant and androgenic mechanisms.
Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit both COX and LOX inflammatory pathways, reducing joint inflammation. A 2025 network meta-analysis of 39 RCTs (4,599 KOA patients) found ginger demonstrated benefits in some WOMAC outcomes for knee OA. Ginger has been used in Ayurvedic medicine for centuries as 'Shunthi' for joint stiffness.
Ginger bioactives (6-gingerol, 6-shogaol) modulate Th1/Th2 immune balance, inhibit mast cell activity, and reduce oxidative stress relevant to allergic responses. A 2025 authoritative systematic review confirmed early clinical evidence for ginger in allergic rhinitis and asthma. Traditional Ayurvedic and Chinese medicine has long used ginger for respiratory and food-related inflammatory responses.
Ginger (Zingiber officinale) stimulates bile secretion, enhances gallbladder motility via CCK release, and provides anti-inflammatory effects relevant to cholecystitis. Animal studies show ginger increases bile flow and reduces biliary cholesterol. Traditional use as a digestive choleretic spans Ayurveda, TCM, and European herbalism.
Ginger (Zingiber officinale) has documented anti-inflammatory and gastroprotective properties. Bioactive compounds 6-gingerol and 6-shogaol inhibit inflammatory mediators in the gastric mucosa. Ginger is used in traditional medicine for gastric complaints worldwide and is included in integrative protocols for gastritis management.
Ginger is consistently included in authoritative reviews among natural products with potent effects on GLP-1 activity. Its active components (gingerols, shogaols) are proposed to stimulate GLP-1 secretion and influence appetite regulation. Evidence comes primarily from in vitro and animal studies, with human metabolic data supporting satiety effects.
Ginger has been studied for hyperuricemia in humans, with a 2015 human study showing ginger supplementation lowered serum uric acid levels in people with hyperuricemia, and another study finding it reduced gout-associated inflammation and pain. Ginger's active compounds inhibit COX-1/COX-2 and 5-LOX pathways relevant to gout inflammation. 6-gingerol also shows moderate xanthine oxidase inhibitory activity in vitro.
Preclinical and clinical research has identified anti-periodontitis effects of ginger through antibacterial activity against Gram-negative periodontal pathogens, suppression of pro-inflammatory cytokines, improvement of periodontal clinical parameters, and potentiation of the antioxidant defense system. A 2025 review (PMC12242689) concluded ginger may diminish inflammation and tissue damage caused by periodontitis.
Ginger (Zingiber officinale) has been used traditionally in Ayurvedic and Unani medicine for headache. Clinical RCTs show ginger reduces pain in acute migraine; a meta-analysis (pooled N=227) found ginger was associated with higher pain-free rates at 2 hours vs. placebo (RR 1.79). It inhibits prostaglandin synthesis and modulates serotonin receptors.
Ginger (Zingiber officinale) contains gingerols and shogaols that activate TRPV1 receptors to increase thermogenesis, enhance satiety via serotonin receptor modulation, and improve lipid metabolism. A 2019 meta-analysis of RCTs found ginger supplementation significantly reduced body weight, waist-to-hip ratio, and fasting glucose in overweight/obese adults.
Multiple RCTs and systematic reviews support ginger's favorable effects on cardiovascular risk factors including triglycerides, LDL cholesterol, blood pressure, and inflammation. An umbrella review documented significant positive influence of ginger on inflammatory indices, blood pressure, blood lipid profile, and glycemic control. Ginger's anti-atherogenic effects are mediated via antioxidant, anti-inflammatory, and vasodilatory mechanisms.
Multiple randomized controlled trials demonstrate that ginger (Zingiber officinale) significantly reduces menstrual blood loss and duration in women with heavy periods. A 2015 placebo-controlled RCT (Kashefi et al., Phytother Res) found 250 mg dried ginger three times daily over three menstrual cycles significantly reduced heavy bleeding measured by pictorial blood loss assessment chart (PBAC). A 2019 RCT also showed ginger enhanced ibuprofen's effectiveness in reducing bleeding duration and improving quality of life.
Ginger has clinically documented antispasmodic, prokinetic, and anti-nausea properties directly relevant to IBS symptoms via 5-HT3 receptor antagonism and prostaglandin modulation. Evidence-based herbal medicine reviews cite ginger for IBS-related bloating, cramping, and nausea with moderate clinical evidence. Traditional use for GI complaints spans Ayurvedic, Chinese, and European medicine for over 2,000 years.
Ginger supplementation has been shown in RCTs and meta-analyses to improve insulin sensitivity markers including HOMA-IR, fasting insulin, and QUICKI in type 2 diabetic patients. A 2018 meta-analysis found ginger showed a significant beneficial effect on glucose control and insulin sensitivity. Ginger reduces oxidative stress in pancreatic beta cells and modulates insulin receptor signaling.
Ginger (Zingiber officinale) is recognized for anti-inflammatory and antioxidant properties that support kidney function by reducing oxidative stress and inflammation. It is cited in the 2018 PubMed systematic review of dietary plants for kidney stone and urinary tract management. Animal studies confirm protection against nephrotoxin-induced renal injury, and multiple kidney-support herbal formula reviews include ginger as a renal supportive agent.
Ginger (Zingiber officinale) has documented anti-inflammatory and antioxidant properties through its active components gingerols and shogaols, which have been shown in preclinical studies to protect kidney tissue by modulating NF-κB inflammatory pathways and reducing oxidative stress. A 2022 review documented its bioactive components' anti-inflammatory effects modulating NF-κB and cytokine pathways relevant to kidney damage protection.
Ginger (Zingiber officinale) has documented anti-inflammatory effects on the gastrointestinal tract through gingerol and shogaol compounds that inhibit NF-κB and COX-2 pathways. Ginger has been used in Ayurveda, TCM, and traditional European herbalism for GI conditions for thousands of years. Modern reviews of leaky gut ingredients and GI barrier support include ginger for its anti-inflammatory mucosal effects, and the 2023 MDPI leaky gut review includes ginger among herbal ingredients.
Ginger (Zingiber officinale) and its active constituents (gingerols, shogaols) demonstrate hepatoprotective effects in multiple animal studies via antioxidant and anti-inflammatory mechanisms, reducing liver enzyme elevations and oxidative liver damage. Traditional use in Ayurvedic, Chinese, and Arab medicine for digestive and liver conditions is extensively documented. Human clinical data specifically for liver detox are limited.
Ginger (Zingiber officinale) has been used in Ayurvedic, TCM, and other traditional systems for respiratory conditions. Preclinical studies show gingerols and shogaols relax airway smooth muscle and reduce airway inflammation. A clinical study found ginger supplementation improved lung function parameters in asthmatic patients.
Multiple systematic reviews and meta-analyses of RCTs confirm oral ginger reduces primary dysmenorrhea pain severity compared to placebo, with effect size similar to NSAIDs. Ginger inhibits prostaglandin synthesis via cyclooxygenase and lipoxygenase pathways. Evidence supports 750–2000 mg/day of ginger powder during the first 3–4 days of the menstrual cycle.
Multiple randomized controlled trials and meta-analyses demonstrate that ginger (Zingiber officinale) significantly improves key components of metabolic syndrome, including fasting blood glucose, HbA1c, insulin resistance (HOMA-IR), and lipid profiles. A 2018 meta-analysis of 10 RCTs (490 individuals) found ginger produced a pooled HbA1c reduction of −1.00 (95% CI: −1.56, −0.44; P < 0.001). A dedicated RCT in MetS patients using 2 g/day for 12 weeks showed significant improvements in triglycerides, fasting blood glucose, and insulin resistance versus placebo. Evidence is consistent across glycemic and lipid endpoints, though effects on blood pressure and BMI are less robust.
Multiple human RCTs and meta-analyses show ginger (Zingiber officinale) modestly improves several metabolic parameters, including glycemic control, lipid profiles, thermogenesis, and body composition. Its bioactive compounds—primarily gingerols and shogaols—appear to act via enzyme inhibition in carbohydrate metabolism, enhanced diet-induced thermogenesis, and improved insulin sensitivity. Evidence is encouraging but limited by small trial sizes and methodological heterogeneity.
Ginger has been used traditionally for headache and nausea across Asian and Middle Eastern medicine systems. Clinically, a meta-analysis of RCTs concluded ginger is safe and effective for acute migraine treatment, with significant pain reduction at 2 hours. A double-blind placebo-controlled RCT (Cephalalgia, 2019) confirmed its acute efficacy when added to standard migraine treatment.
Ginger is among the most evidence-backed natural remedies for morning sickness (nausea and vomiting of pregnancy, NVP). A 2014 systematic review and meta-analysis of 12 RCTs involving 1,278 pregnant women concluded ginger could be considered a possibly effective alternative for NVP. Multiple individual RCTs showed significant reductions in nausea intensity compared to placebo. ACOG states that ginger has shown beneficial effects and can be considered a non-pharmacologic option for NVP.
Ginger (Zingiber officinale) has the strongest natural evidence base for motion sickness among herbal remedies. The European Medicines Agency's Committee on Herbal Medicinal Products classifies dried powdered ginger rhizome as a 'well-established use' for prevention of nausea and vomiting in motion sickness. Multiple RCTs, including a landmark 1982 Lancet trial and a 2003 study in the American Journal of Physiology, have demonstrated its ability to reduce gastric dysrhythmias and nausea symptoms induced by motion. A 2026 systematic review concluded ginger is a reasonably safe, well-tolerated, and effective treatment for motion sickness.
Ginger (Zingiber officinale) is used traditionally in Ayurveda and TCM as a warming expectorant for cold phlegm and congestion. Its anti-inflammatory and expectorant effects reduce airway irritation and promote mucus clearance. Research demonstrates it acts on immune pathways underlying allergic mucus production. It is listed among natural expectorants by WebMD and Healthline.
Ginger (Zingiber officinale) is supported by a 2010 double-blind placebo-controlled RCT (n=74) showing that 2 g/day for 11 days produced moderate-to-large reductions (~25%) in exercise-induced muscle pain (p=0.005 raw ginger; p=0.015 heat-treated). Gingerols and shogaols inhibit COX-1/COX-2 and NF-κB, reducing prostaglandin-driven DOMS.
A 2020 narrative review of RCTs (published in Phytotherapy Research) found that 4 eligible RCTs demonstrated reductions in inflammation after oral and topical ginger administration for DOMS. A widely cited RCT found 2 g/day of raw or heat-treated ginger reduced exercise-induced muscle pain by approximately 25%. Ginger inhibits COX and LOX pathways.
Ginger (Zingiber officinale) is one of the most extensively studied natural antiemetics. Multiple systematic reviews and meta-analyses of RCTs confirm efficacy for nausea and vomiting of pregnancy (NVP), chemotherapy-induced nausea and vomiting (CINV), and postoperative nausea and vomiting. The active constituents gingerols and shogaols act via 5-HT3 receptor antagonism and NK-1 inhibition.
Ginger (Zingiber officinale) has been studied in PCOS through RCTs, showing anti-inflammatory, antioxidant, and insulin-sensitizing properties. A systematic herbal review for PCOS identified ginger among evaluated herbal medicines, and clinical studies show improvements in androgen levels and metabolic markers.
Ginger is listed among botanical supplements studied for PMS, and RCTs of ginger for dysmenorrhea (menstrual cramping, a core PMS symptom) show significant pain reduction. Multiple RCTs find ginger comparable to ibuprofen and mefenamic acid for dysmenorrhea pain, and it is listed among herbs used for PMS in authoritative botanical reviews.
Ginger extract has been shown in a randomized, double-blind, controlled trial (BMC Complementary Medicine and Therapies, 2020) to be equally effective as loratadine in reducing total nasal symptom scores in allergic rhinitis patients. Over 6 weeks in 72 participants, ginger improved runny nose, nasal congestion, sneezing, and quality of life. Its active compounds (gingerols, shogaols, zingerones) act as natural anti-inflammatory and antihistamine agents.
Ginger has strong clinical evidence for reducing postoperative nausea and vomiting (PONV). A systematic review and meta-analysis of 18 publications (2,199 participants) confirmed a pooled protective effect, with ginger oil showing statistically significant reduction in postoperative vomiting versus placebo. Randomized studies show approximately 25–30% reduction in PONV incidence after various surgical procedures.
Ginger has been used across multiple traditional cultures for postpartum recovery, and clinical trials support its use as a galactagogue (increasing breast milk volume) and anti-inflammatory agent. A 2018 Thai RCT found ginger (with fenugreek and turmeric) increased breast milk volume by 49% at 2 weeks and 103% at 4 weeks. NIH LactMed confirms its traditional postpartum use and documents RCT evidence.
Ginger is among the best-evidenced nonpharmacological treatments for nausea and vomiting of pregnancy (NVP). Multiple systematic reviews and RCTs support its efficacy. ACOG states ginger has shown beneficial effects for NVP and considers it a nonpharmacological option; UK NICE includes ginger among acceptable therapies for early pregnancy NVP. An RCT (n=291) found ginger equivalent to vitamin B6 (75 mg/day) for nausea, retching, and vomiting.
Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit COX and LOX enzymes, reducing prostaglandin and leukotriene synthesis involved in RA inflammation. Multiple RCTs found ginger supplementation reduced tender joint counts, morning stiffness, and CRP in RA patients. Typical studied dose is 1,000–1,500 mg/day.
Ginger root contains gingerols and shogaols with anti-inflammatory and antinociceptive properties relevant to sciatica. Pre-clinical studies show ginger polyphenols modulate neuroinflammation and gut-brain axis in spinal nerve ligation neuropathic pain models. A registered randomized placebo-controlled trial is currently evaluating ginger root extract (2000 mg/day) specifically in chronic sciatica patients.
Ginger is used in SIBO management primarily as a natural prokinetic agent that enhances gastric motility and stimulates the migrating motor complex (MMC), reducing bacterial stasis and overgrowth recurrence. Clinical and pharmacological research confirms ginger's prokinetic properties, and clinical SIBO protocols recommend it (500–1,000 mg at night) to prevent relapse by maintaining gut motility after SIBO eradication.
Ginger extract demonstrated efficacy comparable to loratadine for allergic rhinitis symptoms including nasal congestion in a registered double-blind RCT (n=80, 500 mg/day for 6 weeks). Acoustic rhinometry confirmed objectively improved nasal cavity volume in the ginger group. Gingerols and shogaols reduce mast cell infiltration, suppress IgE, and inhibit T-cell activation in nasal mucosa.
Ginger (Zingiber officinale) has evidence supporting its use for sore throat through anti-inflammatory mechanisms. Its active compounds, gingerols and shogaols, inhibit COX-2 and NF-κB pathways that drive pharyngeal inflammation. In vitro and preliminary clinical data support its role in reducing pharyngitis symptoms, and a systematic review (ScienceDirect, 2025) identified it as studied for acute respiratory infections.
Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit COX and LOX enzymes, reducing inflammation and pain. It has been used in traditional Ayurvedic and Chinese medicine for sprains and musculoskeletal injuries, with clinical evidence in musculoskeletal pain conditions.
Ginger (Zingiber officinale) contains shogaols, gingerols, and paradols that activate PGC-1α and thermogenic pathways in adipose tissue. GNC and preclinical research document fat metabolism pathway activation, and shogaols have been identified as specific thermogenic compounds activating PGC-1α in brown and white adipose tissue. It has a long traditional use in Ayurvedic and Chinese medicine for metabolic support.
Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit prostaglandin synthesis, producing anti-inflammatory and analgesic effects. A 2025 PMC systematic review of 21 dental pain clinical studies found ginger powder achieved pain control equivalent to conventional NSAIDs post-dental surgery. The review ranked ginger among only two phytotherapeutics (alongside eugenol) with the most consistent evidence for dental analgesia.
Ginger (Zingiber officinale) has been studied in multiple RCTs and a meta-analysis for lipid-lowering effects including triglyceride reduction in diabetic and metabolic syndrome patients. Gingerols and shogaols modulate lipid metabolism via PPAR activation and inhibition of cholesterol synthesis.
A 2024 randomized double-blind placebo-controlled clinical trial found that 2000 mg/day ginger supplementation after standard peptic ulcer therapy significantly reduced ulcer count (p=0.01) and dyspepsia scores versus placebo. Preclinical evidence consistently shows gastroprotective effects through increasing mucus secretion, antioxidant activity, and H. pylori inhibition.
Ginger (Zingiber officinale) has documented anti-vertigo and motion-sickness-reducing properties supported by multiple RCTs and systematic reviews. A controlled clinical study (Grøntved & Hentzer, 1986) demonstrated a statistically significant vertigo-reducing effect of ginger root. A systematic review of 12 RCTs in 2,630+ subjects and a 2026 PRISMA systematic review of 4 RCTs (469 participants) support ginger's efficacy for motion sickness symptoms including nausea, dizziness, and vertigo.
Ginger (Zingiber officinale) contains shogaols, gingerols, and zingerone with documented antiviral activity against RSV, influenza, adenovirus, and rhinovirus. It modulates cytokine production and NF-κB pathways relevant to viral immune defense. Clinical studies support ginger's use for respiratory viral infections.
Ginger (Zingiber officinale) has long-standing traditional use in Ayurveda, TCM, and folk medicine for bronchial conditions including cough, bronchitis, and asthma, attributed to its expectorant, anti-inflammatory, and immunostimulatory properties. Active compounds—gingerols, shogaols, and zingiberene—have demonstrated anti-inflammatory effects relevant to bronchial conditions in preclinical studies. Multiple herbal medicine reviews identify ginger as a respiratory supportive herb.
Ginger (Zingiber officinale) has traditional use in Ayurveda, TCM, and folk medicine specifically for bronchitis and cough. Anti-inflammatory effects in human bronchial epithelial cells (BEAS-2B) are published (Podlogar and Verspohl, 2012, Phytotherapy Research, PMID 21698672). Systematic reviews note limited high-quality RCT evidence for acute bronchitis specifically.
Ginger has been used for thousands of years in Ayurvedic, Traditional Chinese, and folk medicine systems to soothe childhood digestive complaints including nausea, vomiting, and stomachache. Its bioactive gingerols and shogaols stimulate digestive enzyme secretion, accelerate gastric emptying, and exert antispasmodic effects. While most clinical trial evidence is in adults, traditional pediatric use is cross-culturally widespread.
Ginger (Zingiber officinale) has been used across Asian, European, and Middle Eastern traditional medicine for thousands of years for colds, flu, sore throats, and coughs. Gingerols and shogaols have documented antiviral and anti-inflammatory properties in preclinical studies including anti-RSV and anti-rhinovirus activity. EBSCO lists ginger as an 'other proposed natural treatment' for cold and flu. Clinical RCT evidence specifically for cold/flu is limited.
Ginger (Zingiber officinale) is identified in authoritative herbal sources (Herbal Reality) as a circulatory stimulant and potent anti-inflammatory that can potentiate expectorants and help reduce airway inflammation in COPD. It has a long history in TCM and Ayurvedic medicine for respiratory conditions. Preclinical evidence supports anti-inflammatory effects on airway tissue.
Ginger (Zingiber officinale) has been used in TCM as Sheng Jiang to 'release the exterior' and address early-stage febrile illness with chills, and in Ayurveda for fever management. Small clinical and laboratory studies suggest mild antipyretic and anti-inflammatory effects, though results are inconsistent and evidence quality is low.
Ginger (Zingiber officinale) is noted in traditional herbal medicine as a cholagogue—promoting bile release from the gallbladder—and has been used across Ayurvedic, Chinese, and European medicine for digestive complaints. Some animal studies support its ability to reduce cholesterol absorption and modify bile composition. It is traditionally used to support digestive function related to fat metabolism and biliary flow, though clinical human gallstone evidence is limited.
Ginger is used in Ayurveda as a universal medicine specifically supporting circulatory systems including the lymphatic, digestive, and respiratory systems. As part of the Ayurvedic Trikatu formula, ginger synergistically stimulates the digestive system, promotes healthy metabolism, and encourages detoxification. Its diaphoretic and circulatory-stimulating properties indirectly support lymph flow by increasing fluid movement through surrounding tissues.
Ginger (Zingiber officinale) is recognized in traditional herbal practice as a circulatory stimulant that indirectly supports lymph flow by increasing movement of fluids through surrounding tissues. Clinical nutrition references note ginger increases fibrinolytic activity, reducing fibrin-related tissue stiffness around lymphatic vessels. Anti-inflammatory constituents (gingerols, shogaols) may reduce lymph node inflammatory burden, but no direct lymphatic drainage clinical trials exist.
Ginger (Zingiber officinale) has traditional use in Ayurvedic, Chinese, and African medicine for intestinal parasite conditions. A published in vitro study evaluated ginger extracts against Trichinella spiralis and Trichinella britovi larvae; ginger is included in multiple published natural antiparasitic protocols.
Ginger (Zingiber officinale) is cited in multiple traditional medicine systems and herbalist protocols for pertussis, with reported evidence that it helps with upper respiratory tract infections in children including whooping cough. It appears in traditional whooping cough syrups and integrative medicine sources. Its antimicrobial, anti-inflammatory, and mucolytic properties provide pharmacological plausibility.
Ginger has traditionally been used to address pleurisy symptoms, with its well-documented anti-inflammatory effects attributed to inhibition of prostaglandin synthesis, acting similarly to NSAIDs. Animal studies confirm analgesic effects relevant to pleurisy-associated chest pain. Ginger teas are commonly recommended in traditional and functional medicine contexts for pleurisy.
Ginger (Zingiber officinale) is used in Ayurvedic, Chinese, and Middle Eastern traditional medicine for respiratory infections and chest congestion. Authoritative phytotherapy reviews cite it for respiratory disease management. Active compounds gingerols and shogaols provide anti-inflammatory and antimicrobial properties relevant to pneumonia supportive care.
Ginger (Zingiber officinale) is rated 'promising' in a systematic herbal medicine benefit-risk assessment for COVID-19 respiratory recovery (ScienceDirect, 2021). It contains gingerols and shogaols with anti-inflammatory, antiviral, and antinausea properties relevant to post-viral recovery. Traditional use globally for recovery from fever and respiratory illness spans millennia.
Ginger is used traditionally for hives and rashes in Ayurvedic and Asian folk medicine due to anti-inflammatory and blood-circulation-enhancing properties. Topical ginger juice is applied to reduce redness and itching associated with hives. Scientific evidence is largely limited to preclinical anti-inflammatory data; formal urticaria RCTs are absent.
Ginger has been used in Ayurvedic and Traditional Chinese Medicine for respiratory congestion and sinus infections. Its bioactive compounds (gingerols, shogaols) have anti-inflammatory and antimicrobial properties studied in vitro. Direct clinical trials for sinusitis are lacking; traditional and mechanistic support is established.
Ginger has been used traditionally across Asian, Ayurvedic, and European herbal medicine for sore throat, tonsillitis, and upper respiratory infections. Gingerols and shogaols inhibit NF-κB and prostaglandin synthesis, reducing tonsillar inflammation. Multiple medical and herbal resources specifically cite ginger tea for soothing tonsillitis symptoms, though dedicated RCTs for tonsillitis are lacking.
Ginger (Zingiber officinale) has millennia of traditional use in TCM, Ayurveda, and global folk medicine for upper respiratory infections, cough, sore throat, and fever. Its gingerols and shogaols provide anti-inflammatory, antiviral, and expectorant activities. Clinical RCT evidence for isolated ginger in URTI is limited, but traditional use is globally consistent.
Ginger (Zingiber officinale) root is a traditional digestive tonic used in whole-body cleanse formulations for its ability to stimulate gastrointestinal motility, support bowel function, and reduce digestive inflammation. It is recognized in multiple traditional medicine systems (Ayurveda, TCM, Western herbalism) as a key herb for supporting the digestive tract during cleansing.
Volver